RoodhooftA.M., Van AckerK.J., De BroeM.E.Chylous peritonitis: an infrequent complication of peritoneal dialysis.Perit Dial Int1987; 7: 195–6.
2.
CheungC.K., KhwajaA.Chylous ascites: an unusual complication of peritoneal dialysis. A case report and literature review.Perit Dial Int2008; 28: 229–31.
3.
YoshimotoK., SaimaS., EchizenH., NakamuraY., IshizakiT.A drug-induced turbid peritoneal dialysate in five patients treated with continuous ambulatory peritoneal dialysis.Clin Nephrol1993; 40: 114–17.
4.
YoshimotoK., SaimaS., NakamuraY., NakayamaM., KuboH., KawaguchiY.Dihydropyridine type calcium channel blocker–induced turbid dialysate in patients undergoing peritoneal dialysis.Clin Nephrol1998; 50: 90–3.
5.
YangW.S., HuangJ.W., ChenH.W., TsaiT.J., WuK.D.Lercanidipine-induced chyloperitoneum in patients on peritoneal dialysis.Perit Dial Int2008; 28: 632–6.
6.
HsiaoP.J., LinH.W., SungC.C., WangC.W., ChuP., LinS.H.Incidence and clinical course of lercanidipine associated cloudy effluent in continuous ambulatory peritoneal dialysis.Clin Nephrol2010; 74: 217–22.
7.
VaidyanathanS., ValenciaJ., KempC., ZhaoC., YehC.M., BizotM.N.Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.Int J Clin Pract2006; 60: 1343–56.
8.
KatohM., NakajimaM., ShimadaN., YamazakiH., YokoiT.Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug–drug interactions.Eur J Clin Pharmacol2000; 55: 843–52.
9.
FangC.C., YenC.J., ChenY.M., ChuT.S., LinM.T., YangJ.Y.Diltiazem suppresses collagen synthesis and IL-1β–induced TGF-β1 production on human peritoneal mesothelial cells.Nephrol Dial Transplant2006; 21: 1340–7.
